Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Acid-Base Imbalance | 1 | 2021 | 46 | 0.22 | Why? |
| Palatine Tonsil | 1 | 2021 | 127 | 0.21 | Why? |
| Cobicistat | 1 | 2021 | 172 | 0.20 | Why? |
| Tonsillectomy | 1 | 2021 | 115 | 0.20 | Why? |
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 24 | 0.20 | Why? |
| Immunoglobulin Isotypes | 1 | 2020 | 308 | 0.18 | Why? |
| Hypokalemia | 1 | 2021 | 195 | 0.18 | Why? |
| Herpesvirus 1, Human | 1 | 2021 | 286 | 0.18 | Why? |
| Medical Laboratory Personnel | 1 | 2020 | 254 | 0.18 | Why? |
| Herpes Simplex | 1 | 2021 | 272 | 0.17 | Why? |
| Herpesvirus 7, Human | 1 | 2017 | 18 | 0.17 | Why? |
| Liver Failure, Acute | 1 | 2021 | 279 | 0.17 | Why? |
| Darunavir | 1 | 2021 | 477 | 0.17 | Why? |
| Surface-Active Agents | 1 | 2020 | 267 | 0.17 | Why? |
| Energy Metabolism | 1 | 2020 | 451 | 0.16 | Why? |
| Roseolovirus Infections | 1 | 2017 | 131 | 0.15 | Why? |
| Immunomodulation | 2 | 2021 | 1472 | 0.14 | Why? |
| CD4-Positive T-Lymphocytes | 2 | 2020 | 4545 | 0.14 | Why? |
| Respiratory Therapy | 1 | 2021 | 918 | 0.14 | Why? |
| AIDS Vaccines | 1 | 2019 | 452 | 0.13 | Why? |
| Vasculitis | 1 | 2020 | 691 | 0.13 | Why? |
| Mitochondria | 1 | 2020 | 857 | 0.13 | Why? |
| T-Lymphocyte Subsets | 1 | 2020 | 1387 | 0.12 | Why? |
| CD8-Positive T-Lymphocytes | 2 | 2020 | 5837 | 0.12 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2021 | 1731 | 0.11 | Why? |
| Antibodies, Monoclonal, Humanized | 3 | 2021 | 9335 | 0.11 | Why? |
| Italy | 11 | 2021 | 38444 | 0.11 | Why? |
| Methylprednisolone | 1 | 2021 | 2107 | 0.10 | Why? |
| Encephalitis | 1 | 2017 | 797 | 0.10 | Why? |
| Respiratory Insufficiency | 2 | 2020 | 7301 | 0.09 | Why? |
| Antimalarials | 1 | 2021 | 2505 | 0.09 | Why? |
| DNA, Viral | 1 | 2019 | 2521 | 0.09 | Why? |
| Thrombophilia | 1 | 2021 | 1935 | 0.09 | Why? |
| Anti-HIV Agents | 1 | 2021 | 2209 | 0.09 | Why? |
| Monocytes | 1 | 2020 | 2978 | 0.09 | Why? |
| Heparin | 1 | 2021 | 2600 | 0.09 | Why? |
| Blood Gas Analysis | 2 | 2021 | 893 | 0.08 | Why? |
| Cytokines | 4 | 2021 | 15010 | 0.08 | Why? |
| Pharmaceutical Preparations | 1 | 2021 | 1897 | 0.08 | Why? |
| Computer Simulation | 1 | 2020 | 4982 | 0.07 | Why? |
| B-Lymphocytes | 1 | 2020 | 4418 | 0.07 | Why? |
| Logistic Models | 1 | 2020 | 9089 | 0.07 | Why? |
| Societies, Medical | 1 | 2021 | 6907 | 0.07 | Why? |
| Machine Learning | 1 | 2020 | 4395 | 0.07 | Why? |
| Middle Aged | 18 | 2021 | 270681 | 0.07 | Why? |
| Aged | 16 | 2021 | 215776 | 0.07 | Why? |
| HIV-1 | 1 | 2019 | 3365 | 0.07 | Why? |
| Occupational Health | 1 | 2020 | 3965 | 0.06 | Why? |
| Retrospective Studies | 11 | 2021 | 105322 | 0.06 | Why? |
| Respiration, Artificial | 4 | 2021 | 22116 | 0.06 | Why? |
| Hospital Mortality | 3 | 2021 | 22087 | 0.06 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.06 | Why? |
| Inflammation | 2 | 2021 | 13255 | 0.06 | Why? |
| Male | 18 | 2021 | 367725 | 0.06 | Why? |
| Acute Kidney Injury | 1 | 2021 | 5762 | 0.05 | Why? |
| Female | 17 | 2021 | 380317 | 0.05 | Why? |
| Instillation, Drug | 1 | 2020 | 28 | 0.05 | Why? |
| Lymphocyte Activation | 2 | 2020 | 2742 | 0.05 | Why? |
| Aged, 80 and over | 8 | 2021 | 88759 | 0.05 | Why? |
| Humans | 27 | 2021 | 930598 | 0.05 | Why? |
| Hematuria | 1 | 2021 | 284 | 0.05 | Why? |
| Markov Chains | 1 | 2021 | 502 | 0.05 | Why? |
| Anticoagulants | 1 | 2021 | 9563 | 0.05 | Why? |
| Treatment Outcome | 6 | 2021 | 51732 | 0.05 | Why? |
| Diuretics | 1 | 2021 | 326 | 0.05 | Why? |
| Primary Cell Culture | 1 | 2020 | 501 | 0.05 | Why? |
| Cross Infection | 1 | 2021 | 8675 | 0.05 | Why? |
| Sampling Studies | 1 | 2020 | 386 | 0.05 | Why? |
| Lymphocyte Count | 2 | 2020 | 4758 | 0.04 | Why? |
| Potassium | 1 | 2021 | 325 | 0.04 | Why? |
| Immunologic Memory | 2 | 2020 | 3362 | 0.04 | Why? |
| Proteinuria | 1 | 2021 | 474 | 0.04 | Why? |
| Case-Control Studies | 3 | 2021 | 17671 | 0.04 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2021 | 12447 | 0.04 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.04 | Why? |
| Cellular Senescence | 1 | 2020 | 326 | 0.04 | Why? |
| Survival Analysis | 2 | 2021 | 7592 | 0.04 | Why? |
| Radiculopathy | 1 | 2017 | 79 | 0.04 | Why? |
| Acyclovir | 1 | 2017 | 154 | 0.04 | Why? |
| Protective Clothing | 1 | 2020 | 468 | 0.04 | Why? |
| Practice Guidelines as Topic | 1 | 2021 | 15421 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Programmed Cell Death 1 Receptor | 1 | 2020 | 724 | 0.04 | Why? |
| Immunocompetence | 1 | 2017 | 280 | 0.04 | Why? |
| Bias | 1 | 2021 | 1109 | 0.04 | Why? |
| Pregnancy Complications, Infectious | 1 | 2021 | 11559 | 0.04 | Why? |
| Th17 Cells | 1 | 2020 | 657 | 0.04 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.03 | Why? |
| Chemokines | 1 | 2020 | 1095 | 0.03 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.03 | Why? |
| Organ Dysfunction Scores | 1 | 2020 | 1475 | 0.03 | Why? |
| Standard of Care | 1 | 2021 | 1297 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2021 | 2437 | 0.03 | Why? |
| Pneumonia, Ventilator-Associated | 1 | 2021 | 861 | 0.03 | Why? |
| HIV Infections | 1 | 2019 | 11620 | 0.03 | Why? |
| Prognosis | 3 | 2021 | 32490 | 0.03 | Why? |
| Cluster Analysis | 1 | 2021 | 3001 | 0.03 | Why? |
| Cell Proliferation | 1 | 2020 | 1973 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2020 | 1755 | 0.03 | Why? |
| Ischemia | 1 | 2020 | 901 | 0.03 | Why? |
| Adult | 8 | 2021 | 244371 | 0.03 | Why? |
| Risk Assessment | 3 | 2021 | 25439 | 0.03 | Why? |
| Lung | 1 | 2020 | 31049 | 0.03 | Why? |
| Flow Cytometry | 1 | 2020 | 2393 | 0.03 | Why? |
| Drug Combinations | 1 | 2021 | 3852 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2020 | 17020 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2020 | 3395 | 0.03 | Why? |
| Antibodies, Viral | 2 | 2020 | 51949 | 0.03 | Why? |
| Anti-Retroviral Agents | 1 | 2019 | 1099 | 0.03 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2020 | 5440 | 0.02 | Why? |
| Cross-Sectional Studies | 3 | 2021 | 53120 | 0.02 | Why? |
| Noninvasive Ventilation | 1 | 2021 | 2329 | 0.02 | Why? |
| Oxygen Inhalation Therapy | 1 | 2021 | 3629 | 0.02 | Why? |
| Blood Coagulation | 1 | 2021 | 2768 | 0.02 | Why? |
| Biomarkers | 2 | 2021 | 23361 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Survival Rate | 1 | 2021 | 9206 | 0.02 | Why? |
| Dexamethasone | 1 | 2017 | 2055 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2020 | 4849 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.02 | Why? |
| Sepsis | 1 | 2021 | 3517 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Sex Factors | 1 | 2021 | 11014 | 0.02 | Why? |
| Models, Statistical | 1 | 2020 | 5312 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.02 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2021 | 10649 | 0.01 | Why? |
| Occupational Exposure | 1 | 2020 | 4742 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.01 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.01 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.01 | Why? |
| Viral Load | 1 | 2019 | 15850 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Anti-Inflammatory Agents | 1 | 2017 | 6153 | 0.01 | Why? |
| Masks | 1 | 2020 | 8528 | 0.01 | Why? |
| Critical Illness | 1 | 2021 | 17281 | 0.01 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.01 | Why? |
| Prospective Studies | 1 | 2020 | 43301 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Antiviral Agents | 1 | 2017 | 41703 | 0.00 | Why? |
Meschiari's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(150)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(363)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_